Alva - Your AI Investing Agent

Skip to main content

For You Search Ask Alva Portfolio

Sp3cul8r

Stock Trader, Author of Trading Toward Financial Freedom

17 Jun, 14:48Latest

PTC Therapeutics is a favored biotech pick as Citi sees higher revenue from its Sephience drug than management does, with a $108 price target. The broader biotech sector is also breaking out. x.com x.com

Biotech2k

Biotech Investor, AI-Driven Drug Discovery

25 Aug

Insmed, Protagonist Therapeutics, BridgeBio and Praxis Precision Medicines are the four biotech horsemen with pipelines that could make them mega-caps someday, and they are the only four biotechs that look cheap. x.com

Biotech2k

Biotech Investor, AI-Driven Drug Discovery

24 Mar

Axsome Therapeutics is a one-hit wonder rather than a broad pipeline of blockbusters. It has one good drug in Auvelity, and the rest of its drugs are very weak. Excitement around the upcoming PDUFA date is a chance to sell at a premium price. x.com

Ask Alva about this thesis